Navigation Links
Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
Date:1/29/2008

WESTFORD, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will host its fourth-quarter and full year 2007 conference call on Tuesday, February 12, 2008 at 9:00 a.m. ET.

On the call, President and Chief Executive Officer Michael Davin and Executive Vice President and Chief Financial Officer Timothy Baker will discuss Cynosure's fourth-quarter and full year 2007 financial results, as well as the company's business outlook and growth strategy.

Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at http://www.cynosure.com. The live call also can be accessed by dialing (800) 289-0573 or (913) 312-0980 (confirmation code: 6674831). If you are unable to listen to the live call, the webcast will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, or visit '/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
2. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
3. Access Pharmaceuticals Announces $2.7 Million New Equity
4. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
5. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
6. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
7. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
8. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
9. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
10. Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic
11. Hoya Announces Third Quarter and Nine Month Results for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards ... verification / linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and ... prepared using the CLSI recommended “equal delta” method for linearity testing and is ...
(Date:7/24/2015)... , July 24, 2015 Ryan & ... filed in United States District Court for the Northern District ... persons or entities that purchased the common stock of Avalanche ... between July 31, 2014 and June 15, 2015, inclusive (the ... September 8, 2015, move the Court for appointment as a ...
(Date:7/24/2015)... July 24, 2015 Equity Research ... BioPharma Inc. (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. ... ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ), and ... report on PDL BioPharma can be accessed at ... Composite ended at 5,146.41, down 0.49%, the Dow Jones ...
(Date:7/24/2015)... 2015 Orexigen Therapeutics, Inc. (Nasdaq: OREX ... second quarter 2015 on Thursday, August 6 before the ... business update and discuss the financial results in a ... Time (5:00 a.m. Pacific Time). The live ... 447-0521 (domestic) or (847) 413-3238 (international), participant code 40327229. ...
Breaking Biology Technology:Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... antibodies that react to the sample. The test result can be ... does or does not appear depending on the sample ... It is also possible to print instructional images or text, for ... be used to test quickly and easily for the presence of ...
... Oct. 6 InterMune, Inc. (Nasdaq: ITMN ... and commercialization rights to danoprevir (also known as RG7227 ... Roche Ltd. for $175 million in cash.  In connection ... Roche entered into in October 2006 has been terminated. ...
... That Produces Isobutene From... -- EVRY, France, October 6, 2010 ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Biology Technology:VTT printed hemoglobin test on paper 2InterMune Sells Danoprevir Rights to Roche for $175 Million 2InterMune Sells Danoprevir Rights to Roche for $175 Million 3InterMune Sells Danoprevir Rights to Roche for $175 Million 4Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 2Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 3Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 4Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 5Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 6Global Bioenergies Succeeds in Creating a Bacterial Prototype That Produces Isobutene From Glucose 7
(Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
(Date:7/8/2015)... , July 8, 2015 The ... as this summer,s must have products such as wearables, smart ... as popularity for biometrics based devices continues to rapidly grow.  ... Inc. (NASDAQ: NXTD ), Google Inc. (NASDAQ: GOOG ... FIT ), GoPro, Inc. (NASDAQ: GPRO ) and ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) has ... Market by Application, Technology, Function & Geography - Global ... The next generation biometrics market is expected to ... 17.9% between 2015 and 2020 Travel & ... Safran SA ( France ), NEC ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... the major regulator of virtually all metabolic activities ... vesicular transport and programmed cell death. Dysregulation of ... diseases such as cancer and neurodegenerative disorders. In ... proved pivotal for understanding and manipulating cellular behaviour ...
... previous research suggests that prominent claims of sex differences ... according to an article in the August 22/29 issue ... many common diseases, published research has often considered that ... men vs. women. Many diseases or traits with strong ...
... Genetic testing can be used to help personalize the ... research published in the September 1, 2007, issue of ... of Hematology. This result represents one of the first ... personal medical care. Because individuals metabolize drugs differently, ...
Cached Biology News:All eukaryotic kinases share 1 common set of substrates 2Claims of sex-related differences in genetic association studies often not properly validated 2Genetics determine optimal drug dose of common anticoagulant 2
kismet (dK-20)...
... Thermo Hybaid's unique Electro-4 design allows ... the Electro-4 it is possible to run ... tank, by stacking up to four,horizontal gels. ... adjustable according to the number of gels ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
p230 trans Golgi Purified Anti-Human clone 15, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Biology Products: